A lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR in the presence of lower concentrations of plasma folate.
A lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR in the presence of lower concentrations of plasma folate.
复制标题
DOI:
10.1371/journal.pone.0054544
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Johanning GL
中科院分区:
文献类型:
--
作者:
Piyathilake CJ;Badiga S;Alvarez RD;Partridge EE;Johanning GL
Identification of associations between global DNA methylation and excess body weight (EBW) and related diseases and their modifying factors are an unmet research need that may lead to decreasing DNA methylation-associated disease risks in humans. The purpose of the current study was to evaluate the following; 1) Association between the degree of peripheral blood mononuclear cell (PBMC) L1 methylation and folate, and indicators of EBW, 2) Association between the degree of PBMC L1 methylation and folate, and insulin resistance (IR) as indicated by a higher homeostasis model assessment (HOMA-IR). The study population consisted of 470 child-bearing age women diagnosed with abnormal pap. The degree of PBMC L1 methylation was assessed by pyrosequencing. Logistic regression models specified indicators of EBW (body mass index–BMI, body fat–BF and waist circumference–WC) or HOMA-IR as dependent variables and the degree of PBMC L1 methylation and circulating concentrations of folate as the independent predictor of primary interest. Women with a lower degree of PBMC L1 methylation and lower plasma folate concentrations were significantly more likely to have higher BMI, % BF or WC (OR = 2.49, 95% CI:1.41–4.47, P = 0.002; OR = 2.49, 95% CI:1.40–4.51, P = 0.002 and OR = 1.98, 95% = 1.14–3.48 P = 0.0145, respectively) and higher HOMA-IR (OR = 1.78, 95% CI:1.02–3.13, P = 0.041). Our results demonstrated that a lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR, especially in the presence of lower concentrations of plasma folate.
登录
查看更多内容
影响因子:
6.4
作者:
Daskalos, Alexandros;Nikolaidis, Georgios;Liloglou, Triantafillos
通讯作者:
Liloglou, Triantafillos
影响因子:
11.2
作者:
Bollati, Valentina;Baccarelli, Andrea;Yang, Allen S.
通讯作者:
Yang, Allen S.
影响因子:
3.7
作者:
Estecio, Marcos R. H.;Gharibyan, Vazganush;Shen, Lanlan;Ibrahim, Ashraf E. K.;Doshi, Ketan;He, Rong;Jelinek, Jaroslav;Yang, Allen S.;Yan, Pearlly S.;Huang, Tim H-M.;Tajara, Eloiza H.;Issa, Jean-Pierre J.
通讯作者:
Issa, Jean-Pierre J.
DOI:
10.1136/bmj.c2573
发表时间:
2010-06-15
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Bajos N;Wellings K;Laborde C;Moreau C;CSF Group
通讯作者:
CSF Group
DOI:
10.1097/ede.0b013e3181f20457
发表时间:
2010-11
期刊:
Epidemiology (Cambridge, Mass.)
影响因子:
--
作者:
Baccarelli A;Wright R;Bollati V;Litonjua A;Zanobetti A;Tarantini L;Sparrow D;Vokonas P;Schwartz J
通讯作者:
Schwartz J